Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock
Go back to Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock| (NYSE: RCUS) | Delayed: 25.95 +0.71 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.24 | 52 Week High | $ | |||
| Open | $25.54 | 52 Week Low | $ | |||
| Day High | $26.03 | P/E | N/A | |||
| Day Low | $25.06 | EPS | $ | |||
| Volume | 1,111,195 | |||||
